EXALENZ BIOSCIENCE (Israel) Management Performance Evaluation

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 35px;;'>EXE</div>
Analysis of EXALENZ BIOSCIENCE manpower and management performance that can provide insight into the company performance. Note, an employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with EXALENZ BIOSCIENCE future performance. EXALENZ BIOSCIENCE employes about 17 people. The company is managed by 23 executives with total tenure of roughly 155 years, averanging almost 6.0 years of service per executive having 1.0 employee per reported executive. See also Investing Opportunities.
  Uri Geiger  Chairman
Chairman of the Board
  Susan Alpert  President
Vice President of Regulation
  Ari Soae  President
Vice President-Supply Chain

EXALENZ BIOSCIENCE Management Effectiveness

The company has return on total asset (ROA) of (25.36) % which means that it has lost $25.36 on every $100 spent on asset. This is way below average.

EXALENZ BIOSCIENCE Workforce Comparison

EXALENZ BIOSCIENCE is one of the top stocks in number of employees category among related companies. The total workforce of Diagnostics & Research industry is currently estimated at about 1,248. EXALENZ BIOSCIENCE claims roughly 17.0 in number of employees contributing just under 2% to equities under Diagnostics & Research industry.

EXALENZ BIOSCIENCE Profit Margins

The company has Profit Margin (PM) of (39.93) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (33.86) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.34.

EXALENZ BIOSCIENCE Stakeholders

Uri Geiger Chairman of the Board
Susan Alpert Vice President of Regulation
Ari Soae Vice President-Supply Chain
Eitan Blank Vice President - Operations
Nisim Bilman Vice President - Research & Development
Michal Hershkovitz Vice President-Regulation & Quality Assurance
Ofer Schlesinger Vice President - Research & Development
Mark Hod Vice President of Sales, North America
Roy Golan President Vice President - Finance
Moshe Dori Vice President - Finance
David Stolick CFO
Raphael Werner COO
Ilan Oren CTO
Nachum Shamir Director
Shmuel Rubinstein Director
Saul Yemal External Director
Avi Zigelman External Director
Itai Arkin Director
Sharon Kochan External Director
Gad Keren External Director
Menachem Inbar Director
Einat Zisman Director
Niza Lipshitz External Director

EXALENZ BIOSCIENCE Manpower Efficiency

Return on EXALENZ BIOSCIENCE Manpower

Revenue Per Employee779.4 K
Revenue Per Executive576.1 K
Net Loss Per Employee311.2 K
Net Loss Per Executive230 K
Working Capital Per Employee1.5 M
Working Capital Per Executive1.1 M
See also Investing Opportunities. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.
Company logos by clearbit